Health

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

The complaint is the latest move in a bitter legal fight between the U.S.'s three largest so-called pharmacy benefit managers, or PBMs, and the FTC.

Trump's selection is sounding the alarm in the public health community and leaving the biotech and pharmaceutical industries cautious of changes to come. 

Henry Schein shares tracked for their best day since 2022 on Monday.

President-elect Donald Trump's return to the White House is poised to have big impacts on consumer health care.

The health care sector has been the big loser in the market since the election.

This week, the company completed the return of Quarter Pounder burgers, with slivered onions, to all restaurant menus nationwide.

Robert F. Kennedy Jr. has been a vocal critic of obesity drugs belonging to the fast-growing GLP-1 class.

Donald Trump had said that if elected president he would have Robert F. Kennedy Jr. "go wild on health." HHS oversees Medicare, Medicaid, the CDC and the FDA.

Shares of Moderna, Novavax, Pfizer, BioNTech and GSK closed lower on Thursday.